US Stock MarketDetailed Quotes
RAPT RAPT Therapeutics
- 2.120
- -0.080-3.64%
Close Oct 31 16:00 ET
- 2.110
- -0.010-0.47%
Post 16:06 ET
74.00MMarket Cap-677P/E (TTM)
2.270High2.090Low310.00KVolume2.200Open2.200Pre Close675.69KTurnover0.98%Turnover RatioLossP/E (Static)34.90MShares27.35052wk High0.68P/B66.90MFloat Cap1.64052wk Low--Dividend TTM31.55MShs Float51.210Historical High--Div YieldTTM8.18%Amplitude1.640Historical Low2.179Avg Price1Lot Size
About RAPT Therapeutics Company
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.
Company Profile
SymbolRAPT
Company NameRAPT Therapeutics
Listing DateOct 31, 2019
Issue Price12.00
Founded2015
CEODr. Brian Russell Wong, M.D.,PhD
MarketNASDAQ
Employees131
Fiscal Year Ends12-31
Address561 Eccles Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-489-9000
Websitehttp://rapt.com
Company Executives
- Name
- Position
- Salary
- Dr. Brian Russell Wong, M.D.,PhD
- President, Chief Executive Officer and Director
- 6.59M
- Rodney Young
- Principal Accounting Officer, Chief Financial Officer and Secretary
- 2.18M
- Dirk G. Brockstedt, PhD
- Chief Scientific Officer
- --
- Dr. William Ho, PhD
- Chief Medical Officer
- 1.90M
- William J. Rieflin
- Chairman of the Board
- 300.28K
- Dr. Mary Ann Gray,PhD
- Independent Director
- 277.78K
- Linda Kozick
- Independent Director
- 260.78K
- Dr. Wendye Robbins, M.D.
- Independent Director
- 265.28K
- Dr. Michael F. Giordano, M.D.
- Independent Director
- 267.78K
- Lori Lyons-Williams
- Independent Director
- 262.28K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
